157 related articles for article (PubMed ID: 37474689)
21. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
22. Impact of Lymph Node Dissection on Thymic Malignancies: Multi-Institutional Propensity Score Matched Analysis.
Hwang Y; Kang CH; Park S; Lee HJ; Park IK; Kim YT; Lee GD; Kim HR; Choi SH; Kim YH; Kim DK; Park SI; Shin S; Cho JH; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
J Thorac Oncol; 2018 Dec; 13(12):1949-1957. PubMed ID: 30217490
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.
Korst RJ; Bezjak A; Blackmon S; Choi N; Fidias P; Liu G; Marx A; Wright C; Mock S; Rutledge JR; Keshavjee S
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):36-44, 46.e1. PubMed ID: 24139613
[TBL] [Abstract][Full Text] [Related]
24. Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models.
Costa B; Estrada MF; Mendes RV; Fior R
Cells; 2020 Jan; 9(2):. PubMed ID: 31991800
[TBL] [Abstract][Full Text] [Related]
25. Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies.
Lee JH; Kim H; Lee SH; Ku JL; Chun JW; Seo HY; Kim SC; Paik WH; Ryu JK; Lee SK; Lowy AM; Kim YT
Gut Liver; 2022 Jul; 16(4):625-636. PubMed ID: 34916338
[TBL] [Abstract][Full Text] [Related]
26. The application of pancreatic cancer organoids for novel drug discovery.
Melzer MK; Resheq Y; Navaee F; Kleger A
Expert Opin Drug Discov; 2023 Apr; 18(4):429-444. PubMed ID: 36945198
[TBL] [Abstract][Full Text] [Related]
27. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
[TBL] [Abstract][Full Text] [Related]
28. A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.
Gbolahan OB; Porter RF; Salter JT; Yiannoutsos C; Burns M; Chiorean EG; Loehrer PJ
J Thorac Oncol; 2018 Dec; 13(12):1940-1948. PubMed ID: 30121390
[TBL] [Abstract][Full Text] [Related]
29. Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors.
Chen CC; Li HW; Wang YL; Lee CC; Shen YC; Hsieh CY; Lin HL; Chen XX; Cho DY; Hsieh CL; Guo JH; Wei ST; Wang J; Wang SC
Sci Rep; 2022 Sep; 12(1):16399. PubMed ID: 36180511
[TBL] [Abstract][Full Text] [Related]
30. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
31. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models.
Tiriac H; French R; Lowy AM
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009658
[TBL] [Abstract][Full Text] [Related]
32. State-matched organoid models to fight pancreatic cancer.
Melzer MK; Roger E; Kleger A
Trends Cancer; 2022 Jun; 8(6):445-447. PubMed ID: 35370114
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.
Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592
[TBL] [Abstract][Full Text] [Related]
34. WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.
Oji Y; Inoue M; Takeda Y; Hosen N; Shintani Y; Kawakami M; Harada T; Murakami Y; Iwai M; Fukuda M; Nishida S; Nakata J; Nakae Y; Takashima S; Shirakata T; Nakajima H; Hasegawa K; Kida H; Kijima T; Morimoto S; Fujiki F; Tsuboi A; Morii E; Morita S; Sakamoto J; Kumanogoh A; Oka Y; Okumura M; Sugiyama H
Int J Cancer; 2018 Jun; 142(11):2375-2382. PubMed ID: 29322496
[TBL] [Abstract][Full Text] [Related]
35. [Organoids from pancreatic ductal adenocarcinoma].
Dusetti N; Iovanna J
Med Sci (Paris); 2020 Jan; 36(1):57-62. PubMed ID: 32014099
[TBL] [Abstract][Full Text] [Related]
36. An Organoid-Based Preclinical Model of Human Gastric Cancer.
Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
[TBL] [Abstract][Full Text] [Related]
37. Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.
Liang Y; Padda SK; Riess JW; West RB; Neal JW; Wakelee HA
Lung Cancer; 2015 Jan; 87(1):34-8. PubMed ID: 25443273
[TBL] [Abstract][Full Text] [Related]
38. Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma.
Farshadi EA; Chang J; Sampadi B; Doukas M; Van 't Land F; van der Sijde F; Vietsch EE; Pothof J; Koerkamp BG; van Eijck CHJ
Clin Cancer Res; 2021 Dec; 27(23):6602-6612. PubMed ID: 34580113
[TBL] [Abstract][Full Text] [Related]
39. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Modelling of PDA: Is Organoid the New Black?
D'Agosto S; Andreani S; Scarpa A; Corbo V
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
